For citations:
Laktionov KK, Yudin DI, Breder VV, Reutova EV, Laktionov KP, Marinov DT, Peregudov DA, Ardzinba MS. A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation. Meditsinskiy sovet = Medical Council. 2019;(10):110-114. (In Russ.) https://doi.org/10.21518/2079-701X-2019-10-110-114